Johnson & Johnson (JNJ)

JNJ (NYSE:Drugs) EQUITY
$125.00
pos +0.54
+0.43%
Today's Range: 124.34 - 125.21 | JNJ Avg Daily Volume: 7,038,900
Last Update: 07/29/16 - 12:17 PM EDT
Volume: 1,538,478
YTD Performance: 21.16%
Open: $124.34
Previous Close: $124.46
52 Week Range: $81.79 - $126.07
Oustanding Shares: 2,750,644,288
Market Cap: 343,197,887,814
6-Month Chart
TheStreet Ratings Grade for JNJ
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 7 7 7
Moderate Buy 2 2 2 2
Hold 9 8 8 7
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.26 2.22 2.22 2.18
Latest Dividend: 0.80
Latest Dividend Yield: 2.56%
Dividend Ex-Date: 08/19/16
Price Earnings Ratio: 22.73
Price Earnings Comparisons:
JNJ Sector Avg. S&P 500
22.73 23.50 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
10.65% 25.69% 34.07%
GROWTH 12 Mo 3 Yr CAGR
Revenue -5.70 0.00 0.01
Net Income -5.60 0.50 0.13
EPS -3.90 0.40 0.12
Earnings for JNJ:
EBITDA 22.04B
Revenue 70.07B
Average Earnings Estimates
Qtr (09/16) Qtr (12/16) FY (12/16) FY (12/17)
Average Estimate $1.63 $1.58 $6.69 $7.09
Number of Analysts 10 8 10 12
High Estimate $1.67 $1.64 $6.70 $7.31
Low Estimate $1.59 $1.55 $6.67 $6.89
Prior Year $1.49 $1.44 $6.20 $6.69
Growth Rate (Year over Year) 9.73% 9.81% 7.84% 6.05%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Time to lock in gains in JNJ.
There are plenty of doubters about the market and its record highs.
Valeant could rake in more than $1 billion annually in new sales after FDA approval of a key drug.
It depends on the type of test and who's doing the grading.
Netflix underwhelmed analysts as subscriber growth came up short.
Let me give you the unassailable themes.
He needs Mondelez to make a deal -- any deal.
They need to do something that makes them stand out as stocks you want to own, not avoid.
Bullish
Jul 08, 2016 | 7:39 AM EDT
Shares of JNJ now seen reaching $125, according to Barclays. Estimates also upped, given buyback activity. Overweight rating.
Charts point to a $174 price target for the cosumer-goods giant.

Columnist Conversations

Thursday's Philadelphia Inquirer reported that the average requested increase for individual health insurance ...
Markets set to open slightly lower as second quarter GDP comes in at a much lower than expected 1.2% and first...
I have a new non-trade-related article published on Seeking Alpha today. http://seekingalpha.com/articl...
From Real Money's Tony Owusu: Amazon (AMZN) continued its strong run of success Thursday afternoon following...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.